Company performance
Add to research
Current Price
as of Jun 18, 2025$73.98
P/E Ratio
49.43
Market Cap
$43.4B
Description
Add to research
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Metrics
Add to research
Overview
- HQIrvine, CA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerEW
- Price$73.98+0.97%
Trading Information
- Market cap$43.40B
- Float97.97%
- Average Daily Volume (1m)3,835,117
- Average Daily Volume (3m)4,563,059
- EPS$1.50
Company
- Revenue$5.54B
- Rev growth (1yr)-11.61%
- Net income$365.20M
- Gross margin77.93%
- EBITDA margin30.88%
- EBITDA$436.30M
- EV$39.47B
- EV/Revenue7.13
- P/E49.43
- P/S7.85
- P/B4.28
- Debt/Equity6.91
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account
StreetAccount Metrics Recap - Edwards Lifesciences Q3 Earnings ($68.34, 0.00) (2023-10-25T20:22:05Z)
Factset